Oramed Pharmaceuticals (ORMP) Enterprise Value (2010 - 2026)
Oramed Pharmaceuticals (ORMP) posted Enterprise Value of -$18.2 million for Q1 2026, up 64.63% on a QoQ basis from -$51.4 million in Q4 2025, and up 77.04% year-over-year from -$10.3 million in Q1 2025.
Oramed Pharmaceuticals (ORMP) Enterprise Value (2010 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Enterprise Value history runs 17 years deep, the most recent figure standing at -$18.2 million for Q1 2026.
- Quarterly Enterprise Value rose 77.04% year-over-year to -$18.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.2 million (up 77.04% YoY) and the FY2025 annual result came in at -$51.4 million, up 38.94% from the prior year.
- Enterprise Value was -$18.2 million for Q1 2026 at Oramed Pharmaceuticals, up from -$51.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$3.1 million in Q2 2025 and bottomed at -$155.0 million in Q3 2022.
- A 5-year average of -$89.6 million and a median of -$87.4 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 994.12% — and 2025, when it surged 96.42%.
- Oramed Pharmaceuticals' Enterprise Value stood at -$152.6 million in 2022, then jumped by 55.65% to -$67.7 million in 2023, then slipped by 24.27% to -$84.1 million in 2024, then jumped by 38.94% to -$51.4 million in 2025, then surged by 64.63% to -$18.2 million in 2026.
- Business Quant data shows ORMP's Enterprise Value at -$18.2 million in Q1 2026, -$51.4 million in Q4 2025, and -$75.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | -18.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.17 Mn |
| Dec 31, 2025 | -51.36 Mn |
| Sep 30, 2025 | -75.33 Mn |
| Jun 30, 2025 | -3.13 Mn |
| Mar 31, 2025 | -79.13 Mn |
| Dec 31, 2024 | -84.13 Mn |
| Sep 30, 2024 | -100.48 Mn |
| Jun 30, 2024 | -87.44 Mn |
| Mar 31, 2024 | -99.78 Mn |
| Dec 31, 2023 | -67.70 Mn |
| Sep 30, 2023 | -126.53 Mn |
| Jun 30, 2023 | -7.99 Mn |
| Mar 31, 2023 | -152.29 Mn |
| Dec 31, 2022 | -152.63 Mn |
| Sep 30, 2022 | -154.98 Mn |
| Jun 30, 2022 | -127.95 Mn |
| Mar 31, 2022 | -134.46 Mn |
| Nov 30, 2021 | -38.92 Mn |
| Aug 31, 2021 | -87.55 Mn |
| May 31, 2021 | -63.55 Mn |